US.CAH · Cardinal Health

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.27757942784833,
        "turnoverUsdM": 265.34963924,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.CAH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 211.1908,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.6,
      "take_profit_price": 232.3335,
      "target_multiplier": 1.9,
      "technical_strength": 1.65,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.55515885569666,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 47.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 46.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 1
  },
  "market": {
    "ma20": 234.7635,
    "ma50": 232.9424,
    "close": 221.27,
    "prevClose": 222.04,
    "avgVolume20": 1661308,
    "volumeRatio": 0.72,
    "changePercent": -0.35
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 1,
    "details": {
      "ret_5d": -0.048464739333651696,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 1,
      "vcp_bonus": 0,
      "vol_ratio": 0.718912235284815,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 1.0443053183168869,
      "volat_points": 0,
      "day_range_pct": 0.021150585257829688,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 47.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 60,
        "contribution": 3
      },
      {
        "raw": 5.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 26,
        "contribution": 5.2
      },
      {
        "raw": 10.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 68,
        "contribution": 10.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 14.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 47.67,
        "contribution": 14.3
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 46.1,
    "details": [
      "基本面分析總分: 3/5分",
      "資金流分析總分: 5.2/20分",
      "市場環境分析總分: 10.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 14.3/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3,
      "資金流": 5.2,
      "市場環境": 10.2,
      "情緒分析": 4,
      "技術信號": 14.3,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.2,
          "epsPoints": 0.4,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 265.34963924,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.CAH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.21
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 718.2184960000001,
                "ma50": 711.4151976999997,
                "name": "QQQ",
                "close": 741.21002,
                "points": 2
              },
              "spy": {
                "ma20": 765.28299795,
                "ma50": 760.9057979799998,
                "name": "SPY",
                "close": 767.81,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.27757942784833,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142344111,
                "url": "https://finnhub.io/api/news?id=ddbb1b005d80edd972afb34b9fb792faf60695dfced9605ca4ba1f91a805d05f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the latest trading session, Cardinal Health (CAH) closed at $222.04, marking a -1.64% move from the previous day.",
                "category": "company",
                "datetime": 1790115304,
                "headline": "Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know"
              },
              {
                "id": 142337859,
                "url": "https://finnhub.io/api/news?id=5e90da72b9445f8f269fe769a77eee231cb102829bca91c22fcabee80a02ffe0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?"
              },
              {
                "id": 142337838,
                "url": "https://finnhub.io/api/news?id=6db76a3f8a212cf94262559026cc82388f79f756fb940a1139660d6696c625e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?"
              },
              {
                "id": 142337936,
                "url": "https://finnhub.io/api/news?id=b0fa32704cad543f7f67cf49fe6423570ab5a742158d34eec27f8fc36b83acf6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "According to the average brokerage recommendation (ABR), one should invest in Cardinal (CAH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
                "category": "company",
                "datetime": 1790083803,
                "headline": "Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?"
              },
              {
                "id": 142262611,
                "url": "https://finnhub.io/api/news?id=51e65494213bb0400c0349c58f22fe3f21acfa3eb6a430626d35ba8b5d581880",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Healthcare services and products company Cardinal Health (NYSE:CAH)’s shares are up by more than 10% year-to-date but are down by more than 8% since early September. Cramer discussed the firm’s share price performance in his morning appearance on September 15th and wondered whether the weakness was due to a rotation into AI stocks rather than […]",
                "category": "company",
                "datetime": 1789773213,
                "headline": "Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better"
              },
              {
                "id": 142198301,
                "url": "https://finnhub.io/api/news?id=5d8969518664096ac716935e597abca1b39eb34fc3063b775fe77eab0320ed67",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.",
                "category": "company",
                "datetime": 1789575420,
                "headline": "Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?"
              },
              {
                "id": 142169748,
                "url": "https://finnhub.io/api/news?id=d2f9a13a78eb72304c5f463faa3ecf4070f7fd750faee6857f080b19b1c6a283",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "The latest trading day saw Cardinal Health (CAH) settling at $232.36, representing a -1.08% change from its previous close.",
                "category": "company",
                "datetime": 1789509602,
                "headline": "Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 142168977,
                "url": "https://finnhub.io/api/news?id=eeef09be0801d058676a026cfc0ece83b45be9bc4754500a2ee5909255de3c8e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (CAH) 2026 Global Healthcare Conference September 15, 2026 9:05 AM EDTCompany ParticipantsDavid Frost - Vice President of Investor...",
                "category": "company",
                "datetime": 1789495901,
                "headline": "Cardinal Health, Inc. (CAH) Presents at 2026 Global Healthcare Conference Transcript"
              }
            ],
            "raw_source": [
              {
                "id": 142356738,
                "url": "https://finnhub.io/api/news?id=21e15ff8939138213840552d1c3bc509a44aadc76ba9d923028b76bcfaa6274f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Profiles 3M, Medline, Cardinal Health, Medtronic and DuPont, covering competitors, segments, regional shares, trends and opportunities. Medical Textile Market Medical Textile Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- \"Medical Textile Market Global Report 2026\" has been added to ResearchAndMarkets.com's offering. Medical Textile Market to Reach $64.28 Billion by 2030 as Healthcare Demand Accelerates The global medical textile market is experiencing exponential growth, supported by rising",
                "category": "company",
                "datetime": 1790160660,
                "headline": "Medical Textile Market Global Report 2026: A $39.53 Billion Revenue Surge to $64.28 Billion by 2030 at 26.9% CAGR, Benchmark 3M, Medline Industries, Cardinal Health,  and DuPont to Secure Market Share"
              },
              {
                "id": 142356184,
                "url": "https://finnhub.io/api/news?id=4ead5a736f279d0cb06e4092bbece1405cc2367363f17bce8f873045bd8a2f86",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
                "category": "company",
                "datetime": 1790157422,
                "headline": "2 Large-Cap Stocks with Solid Fundamentals and 1 We Brush Off"
              },
              {
                "id": 142344111,
                "url": "https://finnhub.io/api/news?id=ddbb1b005d80edd972afb34b9fb792faf60695dfced9605ca4ba1f91a805d05f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the latest trading session, Cardinal Health (CAH) closed at $222.04, marking a -1.64% move from the previous day.",
                "category": "company",
                "datetime": 1790115304,
                "headline": "Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know"
              },
              {
                "id": 142337859,
                "url": "https://finnhub.io/api/news?id=5e90da72b9445f8f269fe769a77eee231cb102829bca91c22fcabee80a02ffe0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?"
              },
              {
                "id": 142337838,
                "url": "https://finnhub.io/api/news?id=6db76a3f8a212cf94262559026cc82388f79f756fb940a1139660d6696c625e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?"
              },
              {
                "id": 142337936,
                "url": "https://finnhub.io/api/news?id=b0fa32704cad543f7f67cf49fe6423570ab5a742158d34eec27f8fc36b83acf6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "According to the average brokerage recommendation (ABR), one should invest in Cardinal (CAH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
                "category": "company",
                "datetime": 1790083803,
                "headline": "Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?"
              },
              {
                "id": 142315822,
                "url": "https://finnhub.io/api/news?id=3e59c5a142d490e9f2d3d2ec72f8bffda0c3472f6744f8f7756c20aa1a5b6325",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cencora (NYSE:COR) executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing demand in oncology and retina, expanded physician-services capabilities and momentum in its international businesses. Speaking at the Morgan Stanley Global Heal",
                "category": "company",
                "datetime": 1790031728,
                "headline": "Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027"
              },
              {
                "id": 142314917,
                "url": "https://finnhub.io/api/news?id=d6784d87f4a81c3449c9561cd8145247cc7c202846e1a6a72ba888cac161c646",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS raises its 2026 revenue and earnings outlook, but reimbursement pressure, macro headwinds and soft front-store demand could weigh on results.",
                "category": "company",
                "datetime": 1790006880,
                "headline": "Here's What Might Affect CVS Health's 2026 Financial Outlook"
              },
              {
                "id": 142308858,
                "url": "https://finnhub.io/api/news?id=3bb5b5a455323b2d2625a5ec535d1f0028338bbb38d12411de24647de5bcea27",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cencora (NYSE:COR) executives highlighted the company’s specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference discussion, while reaffirming the durability of its relationship with Walgreens. Chief Executive Offi",
                "category": "company",
                "datetime": 1789984924,
                "headline": "Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference"
              },
              {
                "id": 142275861,
                "url": "https://finnhub.io/api/news?id=95acd1f635a48b51eaf39db8878981fa064cecf96174bc5bb8234798f279d408",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what he described as a “constructive” period. Speaking at the Morgan Stanley Global Healthcare Confere",
                "category": "company",
                "datetime": 1789855317,
                "headline": "Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds"
              },
              {
                "id": 142273012,
                "url": "https://finnhub.io/api/news?id=62e5cf6e2c94a2481ea7397ee2ba4c59fd3c08a88cbda805faa70b35eefba81a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company’s fiscal 2026 performance was supported by double-digit earnings growth across each of its five operating segments, while fiscal 2027 guidance reflects continued growth from a more normalized base. Speaking at a Baird event, Hollar said t",
                "category": "company",
                "datetime": 1789833722,
                "headline": "Cardinal Health Sees Growth Normalize as Specialty, At-Home Investments Expand"
              },
              {
                "id": 142262612,
                "url": "https://finnhub.io/api/news?id=9156ecf7e86c027bc888c338607f18b47e365681f01ac12302bef887f39a6413",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Life sciences solutions and products provider Thermo Fisher Scientific (NYSE:TMO)’s shares have done well in September and are up by more than 8% since the 10th. On the 15th, Cramer discussed the strength in the shares in a conversation with his co-host David Faber amidst the turmoil in the AI sector on the back of […]",
                "category": "company",
                "datetime": 1789773304,
                "headline": "Jim Cramer Said These 2 Stocks Were Sold Because Of A Rotation – But Is He Right?"
              },
              {
                "id": 142262611,
                "url": "https://finnhub.io/api/news?id=51e65494213bb0400c0349c58f22fe3f21acfa3eb6a430626d35ba8b5d581880",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Healthcare services and products company Cardinal Health (NYSE:CAH)’s shares are up by more than 10% year-to-date but are down by more than 8% since early September. Cramer discussed the firm’s share price performance in his morning appearance on September 15th and wondered whether the weakness was due to a rotation into AI stocks rather than […]",
                "category": "company",
                "datetime": 1789773213,
                "headline": "Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better"
              },
              {
                "id": 142270760,
                "url": "https://finnhub.io/api/news?id=a8243e144bb0c5f7780d839884fdec3451a4733654b7cc2f6f745ff2d11b9ec2",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1789738514,
                "headline": "9 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 142224899,
                "url": "https://finnhub.io/api/news?id=b569c59d9cf8bcb6aa037605376df33f73169cc9b54ac705db0a869a47c744d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.",
                "category": "company",
                "datetime": 1789650540,
                "headline": "BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability"
              },
              {
                "id": 142198301,
                "url": "https://finnhub.io/api/news?id=5d8969518664096ac716935e597abca1b39eb34fc3063b775fe77eab0320ed67",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.",
                "category": "company",
                "datetime": 1789575420,
                "headline": "Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?"
              },
              {
                "id": 142198401,
                "url": "https://finnhub.io/api/news?id=985017d81bf6fe904716bb7385e86080cd8d4c65b304ea898b1013534ac1e4e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health has outperformed the Health Care Services industry over the past year, and analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1789552903,
                "headline": "How Is Cardinal Health's Stock Performance Compared to Other Health Care Services Stocks?"
              },
              {
                "id": 142169748,
                "url": "https://finnhub.io/api/news?id=d2f9a13a78eb72304c5f463faa3ecf4070f7fd750faee6857f080b19b1c6a283",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "The latest trading day saw Cardinal Health (CAH) settling at $232.36, representing a -1.08% change from its previous close.",
                "category": "company",
                "datetime": 1789509602,
                "headline": "Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 142168977,
                "url": "https://finnhub.io/api/news?id=eeef09be0801d058676a026cfc0ece83b45be9bc4754500a2ee5909255de3c8e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (CAH) 2026 Global Healthcare Conference September 15, 2026 9:05 AM EDTCompany ParticipantsDavid Frost - Vice President of Investor...",
                "category": "company",
                "datetime": 1789495901,
                "headline": "Cardinal Health, Inc. (CAH) Presents at 2026 Global Healthcare Conference Transcript"
              },
              {
                "id": 142139634,
                "url": "https://finnhub.io/api/news?id=1540a5e1ee5d3a30af17d96c7d0383ca0d1e6c84f82509b6e90addf3e796c705",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
                "category": "company",
                "datetime": 1789407570,
                "headline": "2 Cash-Producing Stocks Worth Your Attention and 1 We Ignore"
              },
              {
                "id": 142139308,
                "url": "https://finnhub.io/api/news?id=8f218e6f7b910d123201ac23fb800ce70f363d4a3dd35a78f17158dcc3292a09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a gene-editing breakthrough that could reshape medicine.",
                "category": "company",
                "datetime": 1789398055,
                "headline": "AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142137295,
                "url": "https://finnhub.io/api/news?id=dcc4b288ae6e93f54675969bd802a9ab516ad006a056529faa42c98979a51c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-year earnings outlook, citing broad-based growth across its North American Pharmaceutical, Oncology & Multispecialty and Prescription Technology Solutions businesses. Speaking at the Morgan Stanl",
                "category": "company",
                "datetime": 1789390938,
                "headline": "McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal"
              },
              {
                "id": 142138504,
                "url": "https://finnhub.io/api/news?id=b8246181bd53be2d72735e7741b6015f211decc5b5e266e14e6028129b26132a",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (CAH) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 8:30 AM EDTCompany ParticipantsDavid Frost - Vice...",
                "category": "company",
                "datetime": 1789385504,
                "headline": "Cardinal Health, Inc. (CAH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 142135993,
                "url": "https://finnhub.io/api/news?id=da1e88d3e7f35b8059dfd20fd97ed62f63419a669479637d7a9f61c48ee2f6bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value and quality.",
                "category": "company",
                "datetime": 1789383825,
                "headline": "Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142089518,
                "url": "https://finnhub.io/api/news?id=2b34a2a5a93661fb44b03a5ae23beb9474b495656e1ceef30023166f3e89facb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.",
                "category": "company",
                "datetime": 1789150860,
                "headline": "CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?"
              },
              {
                "id": 142087142,
                "url": "https://finnhub.io/api/news?id=d6d0c72b86d9e618670b0425256ff71064320995e71838714d702775481e1376",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years.",
                "category": "company",
                "datetime": 1789141777,
                "headline": "Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142087143,
                "url": "https://finnhub.io/api/news?id=76d994f26a70f0f9c15f617bc2f51be0a2aaee74fdcd41e930440fc7f064cf70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated.",
                "category": "company",
                "datetime": 1789140567,
                "headline": "Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142063302,
                "url": "https://finnhub.io/api/news?id=ad181144a7d06182ba609e0908d03dc6ded85f4ed97764dbd7f7ce1ac0017980",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie's diversified portfolio faces patent headwinds, while Novo Nordisk dominates a faster-growing market, but one trades at a steeper valuation.",
                "category": "company",
                "datetime": 1789062373,
                "headline": "AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142063354,
                "url": "https://finnhub.io/api/news?id=048a492322933b269d7e80caf13a16d0fcc27cc8948d27855f206759fbc84081",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a critical divide for income-focused investors.",
                "category": "company",
                "datetime": 1789057284,
                "headline": "Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142062044,
                "url": "https://finnhub.io/api/news?id=560137700fdb0274b2b3959c029fe5878e28a09596be394126c5f9b6d5d4d425",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1789054203,
                "headline": "Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 142028628,
                "url": "https://finnhub.io/api/news?id=1197e6dcb84032bc3178511ebc59fde338fc46553b3e766a32b3e59929344ec1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli Lilly and Company (NYSE:LLY) rather than chase Johnson & Johnson (NYSE:JNJ) or Cardinal Health (NYSE:CAH). Mad Money host Jim Cramer said: Well, I’ll tell you… I think it’s always good to look at Lilly as a stock […]",
                "category": "company",
                "datetime": 1788981160,
                "headline": "Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks"
              },
              {
                "id": 142025489,
                "url": "https://finnhub.io/api/news?id=47bba7df8cd0884beabbaf391ec5402e0d0ff0dd0ffcf3aeb8b78535c839408c",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (CAH) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:45 AM EDTCompany ParticipantsDavid Frost - Vice President of...",
                "category": "company",
                "datetime": 1788951426,
                "headline": "Cardinal Health, Inc. (CAH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141956423,
                "url": "https://finnhub.io/api/news?id=3f6f83c743ea38a72b4e2871141f4b5f6bc24bd2000d221a4a264cb9b5aaed21",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.",
                "category": "company",
                "datetime": 1788904802,
                "headline": "Cardinal Health (CAH) Declines More Than Market: Some Information for Investors"
              },
              {
                "id": 141951003,
                "url": "https://finnhub.io/api/news?id=684fd4c8d9debc595b5763345e99d26ea2ae7c3263880deb2d9e34ac89cce05f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.",
                "category": "company",
                "datetime": 1788880020,
                "headline": "Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?"
              },
              {
                "id": 141950716,
                "url": "https://finnhub.io/api/news?id=8483fa41d6072ee44cea77dcbda0a547cebf1d856a602d91d28e799874c7640c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation priorities during a presentation with Wells Fargo analyst Stephen Baxter. The company said Precision Medicine Group would expand two areas it has id",
                "category": "company",
                "datetime": 1788872528,
                "headline": "McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates"
              },
              {
                "id": 141455037,
                "url": "https://finnhub.io/api/news?id=882e78db4092ee8e4a4f8c9153c570608198427b13f54f3413147816ac706bb2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead.",
                "category": "company",
                "datetime": 1788547801,
                "headline": "AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141406350,
                "url": "https://finnhub.io/api/news?id=7f06d643160898f1cbdc391a8a9105109c98cd0a5edf1bf978d1a4c97a7e8a62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure to specialty pharmaceuticals and higher-margin healthcare services. Cardinal’s been running circles around McKesson and Cencora. They consistently put up the best numbers because this company has gradually become less of […]",
                "category": "company",
                "datetime": 1788472375,
                "headline": "Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore”"
              },
              {
                "id": 141403880,
                "url": "https://finnhub.io/api/news?id=2e84096df15ac30b56cad9794a7c930f96ca0a6d437a48ac470b179160eb83fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.",
                "category": "company",
                "datetime": 1788463320,
                "headline": "Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen"
              },
              {
                "id": 141398251,
                "url": "https://finnhub.io/api/news?id=328a82c3d457909e88b69b893d71448dd5d5c025b99eb4233343050a4eaa9df2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health's generic volumes, profitable brand-to-generic conversions and Red Oak program continue to support Pharma profits.",
                "category": "company",
                "datetime": 1788441720,
                "headline": "Is Generics Still a Quiet Profit Engine for Cardinal Health?"
              },
              {
                "id": 141379816,
                "url": "https://finnhub.io/api/news?id=819a041077d747de9514891a7a8d48c4ce98210486c4299517df7996e088af63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Since April 2026, Silchester has had a number of discussions with the Company. Silchester has come to hold serious concerns about the Company's fundamental attitude toward its shareholders. Accordingly, on 2 September 2026, Silchester formally demanded, pursuant to Article 297, Paragraph 1 of the Companies Act, that the Company convene an extraordinary general meeting of shareholders (the \"EGM\") to consider the four proposals summarised below. Silchester has asked that the EGM be held no later t",
                "category": "company",
                "datetime": 1788366960,
                "headline": "Silchester International Investors - Press Release and EGM Demand Letter - Medipal Holdings Corporation (7459:JT)"
              },
              {
                "id": 141376742,
                "url": "https://finnhub.io/api/news?id=6357db02e9beba73d4a317034c225b13d7068feb02e840788847e2ae69d50324",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1788360003,
                "headline": "Is Henry Schein (HSIC) Stock Undervalued Right Now?"
              },
              {
                "id": 141376487,
                "url": "https://finnhub.io/api/news?id=10fcefd3355d598d46e8dca783f9778f4475a83f844c22cffff199cadf2d2ae8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026.",
                "category": "company",
                "datetime": 1788356340,
                "headline": "Here's How CVS' Improving Balance Sheet Supports Deleveraging"
              },
              {
                "id": 141377069,
                "url": "https://finnhub.io/api/news?id=d2b0a78c5b2ec6bef921c8a712d6ecb1fbbbb7aa81af14819d5df457b1463590",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CONSHOHOCKEN, Pa., September 02, 2026--Cencora today launched a service to help health systems evaluate, build and scale cell and gene therapy (CGT) programs. Offered through Accelerate Pharmacy Solutions, Cell and Gene Therapy Enablement is designed to help health systems strengthen operational readiness and program execution to reduce barriers to care and expand patient access to advanced therapies.",
                "category": "company",
                "datetime": 1788355800,
                "headline": "Cencora’s Accelerate Pharmacy Solutions Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs"
              },
              {
                "id": 141379924,
                "url": "https://finnhub.io/api/news?id=6afcece2c335857767d8a7dc325db935366d73038876930ff1f2cb2b051c6760",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "The healthcare distributor said the incident affected a subset of customers in its oncology and medical-surgical businesses.",
                "category": "company",
                "datetime": 1788349876,
                "headline": "McKesson confirms data theft in cyberattack involving third-party apps"
              },
              {
                "id": 141373305,
                "url": "https://finnhub.io/api/news?id=9938a6ed856998287cea2992d204673e307eddab99bfdaf3d24d3141ba6cb2df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Henry Schein stock performance snapshot Henry Schein (HSIC) stock has drawn investor attention after recent share price moves, with the company reporting positive total returns over the past year and across multi year periods, alongside reported revenue and net income growth. At the latest share price of US$88.52, Henry Schein has given investors a 16.9% share price return over the past 90 days and a 29.4% total shareholder return over the past year. This suggests momentum has been building...",
                "category": "company",
                "datetime": 1788307678,
                "headline": "Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available?"
              },
              {
                "id": 141361969,
                "url": "https://finnhub.io/api/news?id=a3d2bd9e2e7a1563d69ec569a40caaa48e51f2d5ae1a31d54ca6f34cc56f0cce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026 FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026 AUSTIN, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that Ryan Rhodes, Chief Executive Officer, is schedul",
                "category": "company",
                "datetime": 1788265800,
                "headline": "FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference"
              },
              {
                "id": 141365811,
                "url": "https://finnhub.io/api/news?id=49d383c4145e42a1a0edc062dc4b916919c3a07f62db12935fc0baad823200ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "MD Sass, a boutique asset management firm, published its second-quarter investor update for its flagship, the “MD Sass Concentrated Value Strategy.” The letter can be downloaded here. In the first half of 2026, AI infrastructure stocks led the market, with the Russell 1000 Value increasing by 16.3%, outpacing the S&P 500 (10.2%) and Russell 1000 […]",
                "category": "company",
                "datetime": 1788192071,
                "headline": "Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis"
              },
              {
                "id": 141348564,
                "url": "https://finnhub.io/api/news?id=7009d4f82a8712cebfa86427db9a724d72e0b2b5febcd81764d5d26f56545d3b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.",
                "category": "company",
                "datetime": 1788028861,
                "headline": "AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141361438,
                "url": "https://finnhub.io/api/news?id=940a43f5ddc818d2bd608a743ecdb586ed6fb5e91ade75734e7d1edb77b505aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.",
                "category": "company",
                "datetime": 1788023101,
                "headline": "Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141362279,
                "url": "https://finnhub.io/api/news?id=24b0483fb4d23d2a45eae08e6d6541aacc916e096a9d26974d4a6b6bfd7da4cf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health carries strong pharmacy momentum into H2 2026, with rising prescription volume, Rite Aid gains and higher profit.",
                "category": "company",
                "datetime": 1787846340,
                "headline": "How CVS' Pharmacy & Consumer Wellness Is Positioned for H2 2026"
              },
              {
                "id": 141363637,
                "url": "https://finnhub.io/api/news?id=0009e340eb469a2c2d819aa0627cc009ee92a52abfcd2d125ee0d659256e1f4e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic medical center, Places First Order for LockeT, VTAK’s suture retention device Places its first VIVO 3D Imaging System with a hospital in Germany, one of the largest electrophysiology markets in Europe. FORT MILL, S.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc.’s (NYSE American: VTAK) m",
                "category": "company",
                "datetime": 1787835600,
                "headline": "Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany"
              },
              {
                "id": 141363638,
                "url": "https://finnhub.io/api/news?id=381f009c81a44d952d5b643ae88cfde27e54b5e058c2e9ad1f0d9b32734760d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In August 2026, Cardinal Health reported fourth‑quarter sales of US$63,672 million and net income of US$398 million, alongside a new US$4.00 billion revolving credit facility, a fresh US$5.00 billion share repurchase authorization, and a regular quarterly dividend of US$0.5158 per share. Together with over US$2.08 billion already spent to retire approximately 5.7% of its shares, this combination of earnings growth, expanded liquidity, and stepped-up capital returns highlights management’s...",
                "category": "company",
                "datetime": 1787666723,
                "headline": "What Cardinal Health (CAH)'s New US$5 Billion Buyback and Q4 Results Mean For Shareholders"
              },
              {
                "id": 141363502,
                "url": "https://finnhub.io/api/news?id=0a0c83d8ecf1ecf11da38b06678ec3d7da86b5717bddd2b768f42a4af66175b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.",
                "category": "company",
                "datetime": 1787654564,
                "headline": "2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down"
              },
              {
                "id": 141362494,
                "url": "https://finnhub.io/api/news?id=813bbe30273839d5c9e39751e4840e5380adf79983ce68785f5bc9d92a450f8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson raises fiscal 2027 EPS guidance as oncology, GLP-1 volumes and specialty distribution drive faster profit growth despite cash-flow pressure.",
                "category": "company",
                "datetime": 1787600940,
                "headline": "McKesson Raises FY27 Guidance as Oncology and GLP-1 Growth Accelerate"
              },
              {
                "id": 141362493,
                "url": "https://finnhub.io/api/news?id=a26caf7ebd42adc41c28417195d15ca548d9f7918e53a2033fe7bbaeb5ef1826",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson's double-digit earnings growth, specialty expansion and capital returns support the story, but a premium valuation leaves less room for error.",
                "category": "company",
                "datetime": 1787600940,
                "headline": "Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation?"
              },
              {
                "id": 141363645,
                "url": "https://finnhub.io/api/news?id=264a19181593f4971980165e459392bd4e0b8e274225be280b6620bad4285ede",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH enters fiscal 2027 with strong specialty growth, but IRA pricing changes, GMPD challenges and heavy CapEx pose risks.",
                "category": "company",
                "datetime": 1787600820,
                "headline": "Reasons to Retain Cardinal Health Stock in Your Portfolio for Now"
              },
              {
                "id": 141363639,
                "url": "https://finnhub.io/api/news?id=b7db85ef45fe1225b5c4ba33e3df77c76fea7b53ff2784fcef5628b38adbdff5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including Cardinal Health (NYSE:CAH) and its peers.",
                "category": "company",
                "datetime": 1787593776,
                "headline": "Winners And Losers Of Q2: Cardinal Health (NYSE:CAH) Vs The Rest Of The Healthcare Providers & Services Stocks"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 57,
            "discarded_article_count": 41
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 14.3,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.8,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.8,
            "vcp_reason": "波幅收縮(16.7%→9.4%)；跌縮量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 2,
              "vol_ref": 1738848.2333333334,
              "down_days": 7,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 1884144.7,
              "avg_vol_20": 1668092.35,
              "avg_vol_30": 1738848.2333333334,
              "range_pct_10": 0.09411578614362551,
              "range_pct_20": 0.1265195914493605,
              "range_pct_30": 0.16723907443394942,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.0835590271084996,
              "dist_to_20d_high": 0.11239917816194697,
              "down_shrink_days": 3,
              "breakout_level_20d": 249.28999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.5627619410247111
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.27757942784833,
              "turnoverUsdM": 265.34963924,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.CAH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 211.1908,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.6,
            "take_profit_price": 232.3335,
            "target_multiplier": 1.9,
            "technical_strength": 1.65,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.55515885569666,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 5.0396,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.28
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -149.82
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1811
    },
    "kdj": {
      "d": 14.03,
      "j": -2.94,
      "k": 8.37,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 15.7
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -14030259,
      "recentSlope": -1108665.9,
      "previousSlope": -244820
    },
    "rsi": 11.97,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 240.1129,
      "position": "SAR喺價上",
      "distancePct": 8.52,
      "previousTrend": "下降"
    },
    "ma50": 232.9424,
    "macd": {
      "macd": -3.1537227850030263,
      "trend": "看跌",
      "signal": -1.105026387465398,
      "histogram": -2.0486963975376282
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 233.7631,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.72,
      "score": 2,
      "avgVolume": 1661308,
      "currentVolume": 1199212
    },
    "derived": {
      "ma20": 234.7635,
      "ma50": 232.9424,
      "prevClose": 222.04,
      "avgVolume10": 1901166,
      "avgVolume20": 1661308,
      "changePercent": -0.35,
      "avgVolumeForScore": 1661308
    },
    "ma_cross": {
      "ma20": 234.7635,
      "ma50": 232.9424,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 235.596,
      "prevMa50": 233.1192,
      "spreadPct": 0.78,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 219.5919,
      "upper": 249.9351,
      "position": "中間"
    },
    "rsi_short": 3.05,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.72
    }
  }
}

{
  "close": 221.27,
  "volume": 1199212,
  "changePercent": -0.35
}